C12N 2710/00045
Special targeting system for viral vectors
C12N2710/00045 (Special targeting system for viral vectors) appears on 4 US grants and 5 published applications in this corpus.
Search patents in C12N- Granted patents
- 4
- Published applications
- 5
- Assignees
- 3
- Inventors
- 12
- Latest grant
- 5 Aug 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2018 | 0 | 3 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 3 | 0 |
| 2023 | 0 | 2 |
| 2024 | 0 | 0 |
| 2025 | 1 | 0 |
By publication year.
Recent patents
- Crispr-CAS10 systems and methods for phage genome editing5 Aug 2025US 12,378,577 B2The Board of Trustees of The University of Alabama
- Oncolytic adenoviruses coding for bi-specific antibodies1 Nov 2022US 11,485,791 B2Tilt Biotherapeutics Oy
- Crispr-CAS10 systems and methods for phage genome editing27 Sep 2022US 11,453,892 B2The Board of Trustees of The University of Alabama
- Promoters1 Mar 2022US 11,261,464 B2
- Oncolytic adenoviruses coding for bi-specific antibodies and methods and uses related thereto31 Aug 2023US 2023/0272108 A1Tilt Biotherapeutics Oy
- Crispr-cas10 systems and methods for phage genome editing9 Feb 2023US 2023/0041099 A1The Board of Trustees of The University of Alabama
- Crispr-cas10 systems and methods for phage genome editing6 Sep 2018US 2018/0251787 A1The Board of Trustees of The University of Alabama
- Promoters22 Mar 2018US 2018/0080047 A1Boehringer Ingelheim Vetmedica GmbH
- Oncolytic adenoviruses coding for bi-specific antibodies and methods and uses related thereto15 Mar 2018US 2018/0072809 A1Tilt Biotherapeutics Oy
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.